CalciMedica, Inc. (CALC:NASDAQ) closed at $1.15 on October 22, 2026, unchanged on the day. The stock trades 96.8% below its 52-week high of $36.00 and 15.0% above its 52-week low of $1.00. Over the past year, it lost 61.9%. CalciMedica, Inc. is part of the Health Care sector.
In 252 trading sessions since October 22, 2025, CALC closed higher on 112 days (44%). Its best day was March 9, 2026 (+402.75%) and its worst was January 28, 2026 (-75.59%). The stock moved 10% or more in a single session 32 times. It opened at least 5% above the previous day's high 3 times.
Graybug Vision Inc is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve. The company products under pipeline are; GB-501, a gene therapy delivered via a recombinant adeno-associated virus (AAV) vector to treat corneal clouding caused by mucopolysaccharidosis type 1 (MPS1), and GB-701, a novel and potent small-molecule complement factor B inhibitor being developed to target the complement pathway as a potential treatment for geographic atrophy (GA).
Find more stocks like CALC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.